Compal is pleased to share a new white paper on CGA-QX Docking, presenting a Quantum–AI hybrid workflow designed to accelerate molecular docking and virtual screening for drug discovery.​

Virtual screening plays a critical role in early-stage drug discovery—but screening very large chemical libraries requires both throughput and confidence in ranking.​

Early results show competitive performance on public benchmarks, and case-study experiments suggest that higher-fidelity energy modeling can strengthen correlation with known binding outcomes.​

This reflects Compal’s commitment to practical hybrid computing capabilities—combining accelerated computing today with quantum-ready methods for next-generation workflows.​

​Read and download the full whitepaper here: https://lnkd.in/gpBPXgfX

About Compal

Established in 1984, Compal has grown into a leading global manufacturer of computers and smart devices, partnering with top-tier brands worldwide. In 2025, Compal was recognized by CommonWealth Magazine as one of Taiwan's top 7 manufacturers and has consistently ranked among the Forbes Global 2000 companies. Compal achieved consolidated revenues of USD$24.3 billion in 2025. In recent years, Compal has actively expanded into new growth areas, including cloud servers, automotive electronics, medical technology devices, 5G technologies, and industrial solutions. Headquartered in Taipei, Taiwan, Compal operates design and production facilities in the United States, Taiwan, China, Vietnam, Mexico, Brazil, and Poland, and collaborates with local EMS partners in India and Thailand. For more information, visit: https://www.compal.com

Media Contact

Jack Wang      Vice President & Spokesperson         +886-2-8797-8588            Investor@compal.com